Dental Clearance for Patients with Cardiovascular History
Blood Pressure Control Requirements
- The American College of Cardiology recommends that the critical threshold for proceeding with dental treatment is systolic BP <180 mmHg and diastolic BP <110 mmHg, and if blood pressure exceeds these values, elective procedures should be deferred until better control is achieved 1
- The American Heart Association suggests continuing all antihypertensive medications on the day of dental procedures without interruption, as abruptly stopping beta-blockers and clonidine can lead to life-threatening rebound hypertension risk 1
Medication Management
- The American College of Cardiology recommends that patients with a history of TIA should continue taking antihypertensive medications (ACE inhibitors, ARBs, beta-blockers, or thiazides) and statins for secondary stroke prevention, with a strength of evidence level of A 2, 3
- The American Heart Association suggests that all cardiovascular medications should be continued without interruption during dental procedures, with a strength of evidence level of B 1
Procedure Safety
- The American Dental Association recommends proceeding with local anesthesia containing epinephrine for patients with controlled hypertension, as epinephrine-containing local anesthetics are safe and do not cause significant hemodynamic complications, with a strength of evidence level of C 1
- The American College of Cardiology suggests ensuring adequate postoperative pain control, as pain increases sympathetic tone and blood pressure, with a strength of evidence level of B 1
Risk Factor Optimization
- The American Heart Association recommends maintaining blood pressure <140/90 mmHg (or <130/80 mmHg given the TIA history), with a strength of evidence level of A 2, 3
- The American College of Cardiology suggests that statin therapy is recommended for most patients after atherothrombotic TIA, with a strength of evidence level of A 2, 3
- The American Stroke Association recommends continuing antiplatelet therapy (aspirin or alternative) for patients with a history of TIA, with a strength of evidence level of A 2, 3